Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07062588
PHASE2

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

Sponsor: Angitia Incorporated Limited

View on ClinicalTrials.gov

Summary

This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.

Official title: A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults With Type I, III, or IV Osteogenesis Imperfecta (OI)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2025-12-12

Completion Date

2029-02

Last Updated

2026-01-13

Healthy Volunteers

No

Interventions

DRUG

AGA2115

Subcutaneous injection

OTHER

Placebo

Subcutaneous injection

Locations (26)

Phoenix Children's

Phoenix, Arizona, United States

Yale University School of Medicine

New Haven, Connecticut, United States

Nemours/Alfred I. duPont Hospital for Children

Wilmington, Delaware, United States

Indiana University School of Medicine, Department of Medicine and Pediatrics Division of Endocrinology

Indianapolis, Indiana, United States

Washington University School of Medicine in St. Louis

St Louis, Missouri, United States

University of Nebraska Medical Center (UNMC) - Diabetes and Endocrinology Center

Omaha, Nebraska, United States

New Mexico Clinical Research & Osteoporosis Center, Inc. (NMCROC)

Albuquerque, New Mexico, United States

The Ohio State University Wexner Medical Center (OSUWMC)

Columbus, Ohio, United States

Oregon Health & Science University (OHSU) - The Harold Schnitzer Diabetes Health Center (HSDHC) - Endocrinology Clinic

Portland, Oregon, United States

Vanderbilt University Medical Center (VUMC) - Eskind Diabetes Clinic

Nashville, Tennessee, United States

Instituto de Investigaciones Metabolicas Dr. Zanchetta - Sede Centro

Buenos Aires, Argentina

Monash University-Monash Medical Centre (MMC)

Melbourne, Australia

Royal Melbourne Hospital

Parkville, Australia

Royal North Shore Hospital (RNSH)

Saint Leonards, Australia

Adults Westmead Hospital

Westmead, Australia

University Health Network - Toronto General Hospital - Osteoporosis Clinic

Toronto, Ontario, Canada

Aarhus Universitetshospital - Medicinsk Endokrinologisk Afdeling (MEA) Ambulatoriet - Tage-Hansens Gade

Aarhus, Denmark

Odense Universitetshospital

Odense, Denmark

Hopital Edouard Herriot

Lyon, France

Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Lariboisiere

Paris, France

Leiden University Medical Center (LUMC) - Centrum voor botkwaliteit

Leiden, Netherlands

Erasmus MC

Rotterdam, Netherlands

Isala ziekenhuizen

Zwolle, Netherlands

Cambridge University Hospitals NHS Foundation Trust-Addenbrooke's Hospital

Cambridge, United Kingdom

Lothian Health Board, Western General Hospital

Edinburgh, United Kingdom

Royal National Orthopaedic Hospital NHS Trust

London, United Kingdom